🇦🇪 UAE Stock — At Your Door in 2 Hours  ·  Research Use Only  ·  COA Included with Every Batch
Triple Agonist Research Compound

Retatrutide
Pen

30mg · Prefilled FlexiPen

The most advanced metabolic research compound in its class. Simultaneous GLP-1, GIP, and glucagon receptor activation in a precision-dosing, pH-balanced, ready-to-use format. No reconstitution required.

Order Now →
Retatrutide Pen 30mg — Remy Peptides
Retatrutide Pen 30mg
Remy Peptides
Retatrutide Pen
30mg · Stabilised Solution · pH Balanced
Purity
≥99.2%
Format
FlexiPen
Per Click
0.1mg
Storage
2–8°C
1 Pen(s)
AED 1,200
AED 1,200 per pen
Free UAE delivery on orders over AED 1,500
In Stock — UAE · At Your Door in 2 Hours
⚗️
≥99.2% PurityHPLC Verified · COA Included
🇦🇪
UAE StockDelivered in 2 Hours
🧊
Cold-ChainTemperature Controlled
🔬
Research OnlyFor Qualified Professionals
The Mechanism

Three receptors.
One compound.

01 —
Glucagon-Like Peptide
GLP-1 Receptor
Stimulates insulin secretion, suppresses appetite signalling, and slows gastric emptying. The same pathway targeted by Semaglutide and Liraglutide — but here, one of three simultaneous activations.
02 —
Glucose-Dependent Insulinotropic
GIP Receptor
Works synergistically with GLP-1 to enhance insulin response and shows emerging evidence of direct effects on adipose tissue. Also targeted by Tirzepatide in the dual-agonist class.
03 —
Glucagon Receptor
GCGR Receptor
The differentiator. Co-activation at the glucagon receptor appears to increase energy expenditure, raising metabolic rate — a mechanism unique to the triple-agonist class and absent from all approved GLP-1 therapies.
24%
Mean Body Weight
Reduction — Phase 2
(48 Weeks)
3×
Receptor Pathways
Simultaneously
Activated
Ph.3
Current Trial
Status — Eli Lilly
LY3437943
What's Included
  • Format Prefilled FlexiPen
  • Total Volume 30mg Retatrutide
  • Solution Stabilised · pH Balanced
  • Administration Subcutaneous · Research
  • Needle Gauge 31G · 5mm
  • Storage 2–8°C
  • Purity ≥99.2% HPLC Verified
Box Contents
  • 1× Prefilled FlexiPen (30mg Retatrutide)
  • 20× Pen Needles (5mm 31G)
  • 1× Instruction Leaflet
  • Certificate of Analysis (COA)
Precision Dosing

Click-controlled.
No measuring.

Unlike lyophilised powder formats requiring reconstitution, the Retatrutide Pen eliminates preparation variables entirely. The stabilised solution is pre-mixed, pH-balanced, and ready for research application from the moment it arrives.

Each click of the FlexiPen mechanism delivers a precise 0.1mg dose — allowing researchers to administer consistent, repeatable quantities across study protocols without weighing, mixing, or measuring.

Click Reference Guide
1 Click 0.1mg — minimum increment
10 Clicks 1mg — low study dose
20 Clicks 2mg — moderate study dose
40 Clicks 4mg — standard study dose
60 Clicks 6mg — maximum single dose (full dial)
Total 300 clicks per pen (30mg)
Certificate of Analysis

Third-Party Tested.
Verified Purity.

Every batch is independently tested by Janoshik Analytical — a leading third-party laboratory specialising in pharmaceutical purity analysis. Full test reports are included with every order.

Certificate of Analysis — Janoshik Test Report for Retatrutide 30mg by Remy Peptides
Laboratory
Janoshik Analytical
Batch
RETP002
Purity
99.262%
Date Tested
04 Nov 2025
Certificate of Analysis — Full Size